Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Department of Respiratory Medicine, Agartala Government Medical College, Agartala, Tripura, India.
Front Immunol. 2023 Jan 12;13:985538. doi: 10.3389/fimmu.2022.985538. eCollection 2022.
Tuberculosis (TB) patients show dysregulated immunity, iron metabolism, and anemia. In this study, circulatory cytokines, trace metals, and iron-related proteins (hepcidin, ferroportin, transferrin, Dmt1, Nramp1, ferritin, ceruloplasmin, hemojuvelin, aconitase, and transferrin receptor) were monitored in case (active tuberculosis patients: ATB) and control (non-tuberculosis: NTB and healthy) study populations ( = 72, male: 100%, mean age, 42.94 years; range, 17-83 years). Using serum elemental and cytokine levels, a partial least square discriminate analysis model (PLS-DA) was built, which clustered ATB patients away from NTB and healthy controls. Based on the PLS-DA variable importance in projection (VIP) score and analysis of variance (ANOVA), 13 variables were selected as important biosignatures [IL-18, IL-10, IL-13, IFN-γ, TNF-α, IL-5, IL-12 (p70), IL-1β, copper, zinc, selenium, iron, and aluminum]. Interestingly, low iron and selenium levels and high copper and aluminum levels were observed in ATB subjects. Low circulatory levels of transferrin, ferroportin, and hemojuvelin with higher ferritin and ceruloplasmin levels observed in ATB subjects demonstrate an altered iron metabolism, which partially resolved upon 6 months of anti-TB therapy. The identified biosignature in TB patients demonstrated perturbed iron homeostasis with anemia of inflammation, which could be useful targets for the development of host-directed adjunct therapeutics.
结核病(TB)患者表现出免疫失调、铁代谢和贫血。在这项研究中,监测了循环细胞因子、痕量金属和与铁相关的蛋白质(hepcidin、ferroportin、转铁蛋白、Dmt1、Nramp1、铁蛋白、铜蓝蛋白、血影蛋白、aconitase 和转铁蛋白受体)在病例(活动性肺结核患者:ATB)和对照组(非结核病:NTB 和健康)研究人群中(=72,男性:100%,平均年龄 42.94 岁;范围 17-83 岁)。使用血清元素和细胞因子水平,建立了偏最小二乘判别分析模型(PLS-DA),该模型将 ATB 患者与 NTB 和健康对照组聚类。基于 PLS-DA 变量重要性投影(VIP)得分和方差分析(ANOVA),选择了 13 个变量作为重要的生物标志物[IL-18、IL-10、IL-13、IFN-γ、TNF-α、IL-5、IL-12(p70)、IL-1β、铜、锌、硒、铁和铝]。有趣的是,ATB 患者的铁和硒水平较低,铜和铝水平较高。ATB 患者的转铁蛋白、ferroportin 和血影蛋白循环水平较低,铁蛋白和铜蓝蛋白水平较高,表明铁代谢发生改变,经 6 个月抗结核治疗后部分缓解。在 TB 患者中鉴定的生物标志物显示铁稳态失调伴炎症性贫血,这可能是开发宿主导向辅助治疗的有用靶点。